Journal: Developmental Biology
Article Title: Rab3Gap1 mediates exocytosis of Claudin-1 and tight junction formation during epidermal barrier acquisition
doi: 10.1016/j.ydbio.2013.04.034
Figure Lengend Snippet: Knockdown of Rab3Gap1 prevents cell surface localisation of Claudin-1 and Occludin. Rab3Gap1 rescues Claudin-1 localisation and expression in Ppp2r2a kd cells. ( A) Immunofluoresence of Rab3Gap1 in Scrambled controls and in two shRNA knockdowns of Rab3Gap1 (siRNA1 and siRNA4). (B) Western blot of Rab3Gap1 kd cells of Rab3Gap1, Claudin-1, Rab3a, Occludin, Zo-1, Exoc3 and Psmd4. Gapdh is the loading control. (C) Graph showing the mean percentage intensity in both kd lines (siRNA) compared to Scrambled controls (Scr) after normalisation by Gapdh. Error bars SD, *, p <0.05 **, p <0.005 (2-sided Students T-Test). (D) co-immunofluorescence of Claudin-1 and Rab3, showing peri-nuclear co-localisation in post-confluent Rab3Gap1 kd cells. E. Immunofluorescent analysis of Rab3Gap1 in confluent scrambled and Rab3Gap1 kd confluent keratinocytes. F. Expression of Claudin-1 in confluent scrambled controls, Ppp2r2a kd cells and kd cells transiently transfected with Rab3Gap1 (representative of 2 separate transfections). G. Western blot of Scrambled, Ppp2r2a kd cells and kd cells transfected with a Myc-tagged Rab3Gap1 (arrowhead). Numbers denote fold change in intensity of Claudin-1, Exoc3 and Rab3Gap1 compared to Scrambled controls after normalisation by levels of Gapdh, the loading control Bar 10 µm (A, D, E, F), 50 µm (E (low mag view)).
Article Snippet: Primary antibodies and concentrations were as follows: rabbit anti PR55a (Ppp2r2a) (Santa Cruz Biotechnologies, Santa Cruz, US) 1/500; rabbit anti cJun (Cell Signalling Technologies, Danvers, USA) 1/100; rabbit anti pSer63 cJun (Cell Signalling Technologies, Danvers, USA) 1/100; rabbit anti Claudin-1 (Invitrogen, Paisley, UK) 1/500; mouse anti Occludin (Invitrogen, Paisley, UK ) 1/500; Rabbit anti Zonula Occludins-1 (Santa Cruz Biotechnologies, Santa Cruz, US) 1/500; Mouse anti Rab3 (BD biosciences, Oxford, UK) 1/100.
Techniques: Knockdown, Expressing, shRNA, Western Blot, Control, Immunofluorescence, Transfection